Creative Works & Publications

ORIGINAL ARTICLES:

   1.      Rog-Malinowski M, Sarosiek J, Badurski J, Bernacka K, Stasiewicz  A. Excretion of Hydroxyproline in Urine in Arthritic Patients after Treatment with Radon's Baths in Swieradow Spa. Pol. Tyg. Lek. 27:15-16, 1972.                                             
   2.      Badurski J, Sarosiek J, Gabryelewicz A, Zarzycki W, Glowacka D, Musiatowicz B, Zimnoch L, Popow J. Changes in Gastric Secretory Function in Patients with Chronic Cholecystitis. Przegl. Lek. 30:259-263, 1973.                                                 
   3.      Badurski J, Makosa M, Sarosiek J, Tolwinski T. Application of Indocyanine Green for the Assessment of the Liver Function. Pol. Tyg. Lek. 28:118-120, 1973.
   4.      Sarosiek J, Badurski J, Zwierz K, Kilczewska D, Zarzycki W, Jelski E, Gindzienski A. Gastric Mucus Secretion in Patients with Chronic Duodenal Ulcer. Pol. Tyg. Lek. 29:2117-2119, 1974.
   5.      Badurski J, Sarosiek J, Dadan H, Zaremba A, Zarzycki W, Kopacz-Jodczyk T, Zwierz K, Gindzienski A, Klepacki A. Insulin-Stimulated Secretion of Gastric Mucus in Patients with Duodenal Ulcer after Vagotomy and Pyloroplasty. Pol. Przegl. Chir. 46:637-644, 1974.   
   6.      Sarosiek J, Zamojda B, Rudy J. Caplan-Colinet Syndrome. Med. Pracy 27:231-134, 1976.                                                   
   7.      Sarosiek J, Badurski J, Kiersnowska B, Laszewicz W, Jelski E, Zarzycki W. Mucoproteins of the Gastric Juice in Patients with Pernicious Anaemia. Przegl. Lek. 34:541-545, 1977.                   
   8.      Sarosiek J, Poleszczuk K, Kosc B. Myocardial Infarct During the Treatment with Imipramine. Psych. Pol. 11:237-240, 1977.            
   9.      Sarosiek J, Badurski J. Basal and Maximal Acid and Pepsin Secretion in Patients with Rheumatoid Arthritis. Wiad. Lek. 31:25-31, 1978.                                                               
 10.      Sarosiek J, Badurski J. The Content of Proteins and Carbohydrates in the Gastric Juice in Patients with Rheumatoid Arthritis. Przegl. Lek. 35:349-354, 1978.                                     
 11.      Sarosiek J, Badurski J. A Diagnostic Value of Gastric Mucoproteine Mucoproteose Measurements in Atrophic Gastritis. Diagn. Lab. 14, 21-27, 1978.                                                        
 12.      Sarosiek J, Badurski J. Sulfated and Non-Sulfated Glycoprotein in Gastric Secretion in Patients with Atrophic Gastritis. Pol.        Arch. Med. Wewn. 40:525-533, 1978.                                      
 13.      Sarosiek J, Badurski J. Protein Component and Carbohydrate Composition of Glycoprotein Isolated from the Gastric Juice in Patients with Rheumatoid Arthritis. Pol. Tyg. Lek. 33:125-129, 1978.                                                             
 14.      Rudy J, Sarosiek J. D-Penicillamine and Steroids in the Treatment of Rheumatoid Arthritis. Wiad. Lek. 31:449-455, 1978.             
 15.      Rudy J, Sarosiek J, The Effect of Cuprenil on Serum Copper and  Acute Phase Proteins in Patients with Rheumatoid Arthritis. Rheumatol. Pol. 16:237-244, 1978.                                   
 16.      Sarosiek J, Rudy J. The Therapeutic Value of Cuprenil: Experimental and Clinical Results. Przegl. Lek. 36:337-341, 1979. 
 17.      Rudy J, Sarosiek J, Borejszo I. The Serum Copper and Clinical Efficacy of Penicillamine in Patients with Rheumatoid Arthritis. Przegl. Lek. 35:879-883, 1978.                                     
 18.      Bernacka K, Sarosiek J, Rudy J, Bogdanikowa B. The Effect of Radon Baths on the Serum Level of Immunoglobulins in Rheumatic Diseases Patients. Pol. Tyg. Lek. 34:1587-1590, 1979.                       
 19.      Sarosiek J, Bernacka K, Maciejewska J, Swiderska A, Musiatowicz B. Progressive Exophtalmus in Malignant Lymphoma. Pol. Tyg. Lek. 33: 1891-1892, 1979.                                                    
 20.      Laszewicz W, Sarosiek J, Badurski J. Beta-Glucuronidase Activity and the Content of Mucus Glycoprotein in the Gastric Juice of Patients with Gastric Atrophy. Przegl. Lek. 37:647-50, 1980.    
 21.      Sarosiek J, Gorska M, Bogdanikowa B, Waszkiel B, Jodczyk J. Immunostimulation in the Treatment of Patients with Abnormal Cellular and Humoral Immunity. Pol. Tyg. Lek. 35:877-878, 1980.   
 22.      Gabryelewicz A, Laszewicz W, Sarosiek J. The Influence of Various Gastric Secretory Inhibitors on Peptic Activity. Scand. J. Gastroenterol. 15:(suppl.66), 79-88, 1980.                            
 23.      Sarosiek J, Klepacki A, Badurski J, Zarzycki W. Effect of  Rydygier's Partial Gastrectomy and Vagotomy on the Pentagastrin Stimulated Gastric Mucus and Pepsin Secretion in     Peptic Ulcer Patients. Pol. Tyg. Lek. 36:763-766 (1981).                        
 24.      Sarosiek J, Borejszo I. The Influence of Levamisole on the Gastric Mucous Barrier in Rheumatoid Arthritis Patients. Pol. Tyg. Lek. 36:1231-1234, 1981.                                                
 25.      Sarosiek J, Borejszo I. Leukocyte Adherence Inhibition (LAI) Assay in Gastrointestinal Cancer. Przegl. Lek. 38:478-482, 1981.
 26.      Gabryelewicz A, Sarosiek J, Laszewicz W. The Effect of Ranitidine on Gastric Mucus and Pepsin Secretion in Patients with Peptic Ulcer. A. Med. Polona, 16:226-234, 1981.                          
 27.      Sarosiek J, Slomiany A, Slomiany BL. The Role of Glycoproteins and Lipids in Retardation of Hydrogen Ion Diffusion by Gastric Mucus. IRCS Med. Sci. 11, 351, 1983.                                      
 28.      Witas H, Sarosiek J, Aono M, Murty VLN, Slomiany A, Slomiany BL. Lipids Associated with Rat Small-Intestinal Mucus Glycoprotein. Carbohydr. Res. 120:67-76, 1983.                                  
 29.      Slomiany BL, Murty VLN, Aono M, Sarosiek J, Slomiany A, Mandel ID. Lipids of supragingival Calculus. J. Dent. Res. 62:862-865, 1983. 
 30.      Sarosiek J, Slomiany A, Slomiany BL. Retardation of Hydrogen Ion Diffusion by Gastric Mucus Constituents: Effect of Proteolysis. Biochem. Biophys. Res. Commun. 113:1053-1060, 1983.               
 31.      Sarosiek J, Slomiany BL, Slomiany A, and Gabryelewicz A. Lysolecithin and Glyceroglucolipids in Gastric Secretion of  Patients with  Gastric and Duodenal Ulcer. Scand. J. Gastroenterol. 18:935-938, 1983.                                                
 32.      Sarosiek J, Slomiany BL, Kojima K, Swierczek J, Slomiany A, Konturek S.J. Effect of 16,16-Dimethylprostaglandin E2 and Ethanol on the Constituents of the Gastric Mucosal Barrier. J. Appl. Biochem. 25:429-436, 1983.                                        
 33.      Sarosiek J, Slomiany BL, Slomiany A, Gabryelewicz A. Effect of  Ranitidine on the Content of Glyceroglucolipids in Gastric Secretion of Patients with Gastric and Duodenal Ulcer. Scand. J. Gastroenterol. 19:650-654, 1984.                                        
 34.      Sarosiek J, Slomiany A, Takagi H, Slomiany BL. Hydrogen Ion  Diffusion in Dog Gastric Mucus Glycoprotein: Effect of Associated Lipids and Covalently Bound Fatty Acids. Biochem. Biophys. Res. Commun. 118:523-531, 1984.                                        
 35.      Murty VLN, Sarosiek J, Slomiany A,  Slomiany BL. Effect of Lipids and Proteins on the Viscosity of Gastric Mucus Glycoprotein. Biochem. Biophys. Res. Commun. 121:521-529, 1984.             
 36.      Sarosiek J, Slomiany BL, Swierczek J, Slomiany A, Jozwiak Z, Konturek SJ. Effect of Acetylsalicylic Acid on the Constituents of Gastric Mucosal Barrier. Scand. J. Gastroenterol. 19:150-153. 1984.                                                              
 37.      Slomiany BL, Sarosiek J, Slomiany A. Lipids of Salivary and Gastrointestinal Mucus. N. Y. Med. Quarterly 4:124-130, 1984.   
 38.      Sarosiek J, Slomiany BL, Jozwiak Z, Liau YH, Slomiany A. Rheological Properties of Gastric Mucus Glycoproteins: Contribution of Associated Lipids. In: Annals of N.Y. Acad. Sci.       
            435:575-577, 1984.                                                 
 39.      Slomiany BL, Gabryelewicz A, Sarosiek J, Murty VLN, Slomiany A. Glyceroglucolipids in Gastric Secretion of Patients with Peptic Ulcer Treated with Ranitidine. In: Annals N.Y. Acad. Sci. 435: 205-207, 1984.                                                     
 40.      Slomiany A, Sarosiek J, Takagi A, Konturek SJ, Slomiany BL. Effect of Ethanol on Gastric Mucosa Pretreated with Prostaglandin. In: Annals of N.Y. Acad. Sci. 435: 493-496, 1984.
 41.      Slomiany BL, Piasek A, Sarosiek J, Slomiany A. The Role of Surface and Preformed Intracellular Mucus in Gastric Mucosal Protection Against Hydrogen Ion. Scand. J. Gastroenterol. 20:1191-1196, 1985. 
 42.      Sarosiek J, Bernacka K, Stasiewicz A, Hryszko S, Kuryliszyn A, Wysocka J. Assay of Serum Antiproteases for Assessment of Severity of Rheumatoid Arthritis. Reumatol. Pol. 23:265-272, 1985.
 43.      Sarosiek J, Mizuta K, Slomiany A, Slomiany BL. Effect of  Acetylsalicylic Acid on Gastric Mucin Viscosity, Permeability to Hydrogen Ion and Susceptibility to Pepsin. Biochem. Pharmacol. 35:4291-4295, 1986.                                               
 44.      Slomiany BL, Sarosiek J, Liau YH, Laszewicz W, Murty VLN, Slomiany A. Lysolecithin Affects the Viscosity, Permeability and Peptic Susceptibility of Gastric Mucin. Scand. J. Gastroenterol. 21:1073-1079, 1986.                                               
 45.      Sarosiek J, Murty VLN, Nadziejko C, Slomiany A, Slomiany BL. Prostaglandin Effect on the Physical Properties of Gastric Mucin and Its Susceptibility to Pepsin. Prostaglandins 32:635-646, 1986. 
 46.      Slomiany BL, Sarosiek J, Takagi K, Slomiany A. The Role of Mucus in Gastric Mucosal Protection against Hydrogen Ion. In: Annals of N.Y. Acad. Sci. 463:351-353, 1986.                                  
 47.      Sarosiek J, Bernacka K, Kuryliszyn A. The Serum Antiproteases in Patients with Connective Tissue Diseases. Rheumatol. 24:422-426, 1986.                                                             
 48.      Sarosiek J, Klepacki W, Zarzycki W. The Secretory Function of the Stomach Stimulated with Insulin in Patients with Peptic Ulcer after Rydygier's Gastrectomy. Przegl. Lek. 43:547-551, 1986.
 49.      Kuryliszyn A, Sarosiek J, Bernacka K. The Role of Serum Antiproteases in Monitoring of the Treatment of Patients with Gastric Cancer. Pol. Tyg. Lek. 41:627-631, 1986.                   
 50.      Sarosiek J, Bernacka K, Kuryliszyn A, Stasiewicz A. The Serum Level of Antitrypsin, Antichymotrypsin, Alpha-2-Macroglobulin and HS-Glycoprotein in Rheumatoid Arthritis. Rheumatol. 24:427-433, 1986.                                                        
 51.      Sarosiek J, Kuryliszyn A. Reactive Arthritis. Pol. Tyg. Lek. 42:130-134, 1987.                    
 52.      Sarosiek J, Kuryliszyn A. Polymyositis-Dermatomyositis. Przegl. Lek. 44:345-350, 1987.                                             
 53.      Bernacka K, Lewandowski B, Sarosiek J. Parathyroid Hormone and Calcium-Phosphate Metabolism in Rheumatic Diseases. Reumatol. 25:1-7, 1987.                                                     
 54.      Slomiany BL, Sarosiek J, Slomiany A. Role of Carbohydrates in the Viscosity and Permeability of Gastric Mucus to Hydrogen Ion. Biochem. Biophys. Res. Commun. 142:783-790, 1987.                 
 55.      Slomiany BL, Bilski J, Sarosiek J, Murty VLN, Dworkin B, VanHorn K, Zielenski J, Slomiany A. Compylobacter Pyloridis Degrades Mucin and Undermines Gastric Mucosal Integrity. Biochem. Biophys. Res. Commun. 144: 307-314, 1987.                                       
 56.      Sarosiek J, Bilski J, Tsukada H, Slomiany A, Slomiany BL. Effect of Solon on Gastric Mucus Viscosity, Permeability to Hydrogen Ion and Susceptibility to Pepsin. Digestion 37:238-246, 1987.         
 57.      Bilski J, Sarosiek J, Murty VLN, Aono M, Moriga M, Slomiany A, Slomiany BL. Enhancement of the Lipid Content and Physical Properties of Gastric Mucus by Geranylgeranylacetone. Biochem. Pharmacol. 36: 4059-4065, 1987.                                   
 58.      Slomiany BL, Liau YH, Sarosiek J, Tsukada H, Mizuta K, Rosenthal WS, Slomiany A. Sulfation of Glycolipids by Human Gastric Mucosa in Disease. Digestion 36: 246-252, 1987.                           
 59.      Slomiany BL, Sarosiek J, Slomiany A. Gastric Mucus and the Gastric Mucosal Barrier. Dig. Dis. 5(3):125-145, 1987.                 
 60.      Slomiany BL, Liau YH, Carter SR, Sarosiek J, Tsukada H, Slomiany A. Enzymatic Sulfation  of Mucin in Gastric Mucosa:        Effect of Solon, Sucralfate and Aspirin. Digestion 38: 178-186, 1987.       
 61.      Bilski J, Sarosiek J, Slomiany A, Slomiany BL. Effect of Sofalcone on the Peptic Degradation of Gastric Mucus. In:    Biological Approaches to the Controlled Delivery of Drugs.(Juliano RL, Ed.), Ann. N.Y. Acad. Sci. 507:355-357, 1987.                           
 62.      Sarosiek J, Slomiany A, Slomiany BL. Evidence of Weakening of  Gastric Mucus Integrity by Compylobacter pylori. Scand. J. Gastroenterol. 23:585-590, 1988.                                    
 63.      Slomiany BL, Sarosiek J, Bilski J, Slomiany A. Evidence for Proteolytic Disruption of Gastric Mucus Coat by Compylobacter. S.A. Med. J. 74 (suppl.40):-42, 1988.                                
 64.      Sarosiek J, Mizuta K, Slomiany A, Slomiany BL. Effect of Deglycosylation on Gastric Mucin Viscosity and Acid Impedance. Ann. N.Y. Acad. Sci. 529:254-256, 1988.                           
 65.      Sarosiek J, Bilski J, Murty VLN, Slomiany A, Slomiany BL. Role of Salivary Epidermal Growth Factor in the Maintenance of  Physicochemical Characteristics of Oral and Gastric Mucus Coat. Biochem. Biophys. Res. Commun. 152(3):1421-1427, 1988.               
 66.      Slomiany BL, Murty VLN, Sarosiek J, Piotrowski J, Slomiany A.  Role of Associated and Covalently Bound Lipids in Salivary Mucin Hydrophobicity: Effect of Proteolysis and Disulfide Bridge Reduction. Biochem. Biophys. Res. Commun. 151:1046-1053,1988.
 67.      Bilski J, Murty VLN, Nadziejko C, Sarosiek J, Aono M, Moriga M, Slomiany A, and Slomiany BL. Protection Against Alcohol-Induced Gastric Mucosal Injury by Geranylgeranylacetone: Effect of Indomethacin. Digestion 41: 22-33, 1988.                           
 68.      Sarosiek J, Bilski J, Murty VLN, Slomiany A, Slomiany BL. Colloidal Bismuth Subcitrate (DeNol) Inhibits Degradation of Gastric Mucus by Compylobacter Pylori Protease. Am. J.               
            Gastroenterol. 84:506-510, 1989.                                   
 69.      Slomiany BL, Murty VLN, Sarosiek J, Slomiany A. Enzymatic Sulfation of Mucus Glycoprotein in Submandibular Salivary Gland. Int. J. Biochem. 21:165-171, 1989.                                
 70.      Sarosiek J, Marshall BJ, Peura DA, Hoffman S, Feng T, McCallum RW. Gastroduodenal Mucus Gel Thickness in Patients with Helicobacter pylori: A Method for Assessment in Biopsy Specimens. Am. J. Gastroenterol. 86(6):729-734, 1991.       
 71.      Sarosiek J, Feng T, McCallum RW. The Interrelationship Between Salivary Epidermal Growth Factor and the Functional Integrity of the Esophageal Mucosal Barrier in the Rat. Am. J. Med. Sci. 302(6):359-363, 1991. 
 72.      Sarosiek J, Peura DA, Guerrant RL, Marshall BJ, Laszewicz W, Gabryelewicz A, McCallum RW. Mucolytic Effects of Helicobacter pylori. Scand. J. Gastroenterol. 26(Suppl 187):47-55, 1991.
 73.      McCallum RW, Feng T, Frierson HF, Sarosiek J. A new Experimental Model of Esophagitis in the Cat: The Role of Esophageal Mucus and Bicarbonate in Mucosal Protection Against Peptic Erosion and Back-Diffusion of Hydrogen Ion. Exp. Clin. Gastroenterol. 2(2):90-6, 1992.
 74.      Sarosiek J, Hetzel DP, Yu Z, Piascik R, Li L, Rourk RM, McCallum RW. Evidence on Secretion of Epidermal Growth Factor by the Esophageal Mucosa in Humans. Am. J. Gastroenterol. 88(7):1081-7, 1993.
 75.      Li L, Yu Z, Piascik R, Hetzel DP, Rourk RM, Namiot Z, Sarosiek J, McCallum RW. Effect of Esophageal Intraluminal Mechanical and Chemical Stressors on Salivary Epidermal Growth Factor in Humans. Am. J. Gastroenterol. 88(10):1749-55, 1993.
 76.      Sarosiek J, Namiot Z, McCallum RW. Nitric Oxide as a Mediator of the Esophageal Mucin Secretion under the Impact of Mechanical and Chemical Stimulation. Exp. Clin. Gastroenterol. 3(4):217-24, 1993.
 77.      Namiot Z, Sarosiek J, Rourk RM, Hetzel DP, McCallum RW.  Human Esophageal Secretion: Mucosal Response to Luminal Acid and Pepsin. Gastroenterology 106:973-81,1994.
 78.      Namiot Z, Rourk RM, Piascik R, Hetzel DP, Sarosiek J, McCallum RW. Interrelationship between Esophageal Challenge with Mechanical and Chemical Stimuli and Salivary Protective Mechanisms. Am. J. Gastroenterol. 89(4):581-7,1994.
 79.      Rourk RM, Namiot Z, Sarosiek J, Yu Z, McCallum RW. Impairment of Salivary Epidermal Growth Factor Secretory Response to Esophageal Mechanical and Chemical Stimulation in Patients with Reflux Esophagitis. Am. J. Gastroenterol. 89(2):237-44,1994.
 80.      Sarosiek J, Yu Z, Namiot Z, Rourk RM, Hetzel DP, McCallum RW.  Impact of Acid and Pepsin on Human Esophageal Prostaglandins.  Am. J. Gastroenterol. 89(4):588-94,1994.
 81.      Sarosiek J, McCallum RW.  The Evolving Appreciation of the Role of Esophageal Mucosal Protection in the Pathophysiology of Gastroesophageal Reflux Disease.  Pract. Gastroenterol. 18(4):20J-20Q,1994.
 82.      Rourk RM, Namiot Z, Edmunds MC, Sarosiek J, Yu Z, McCallum RW. Diminished Luminal Release of Esophageal Epidermal Growth Factor in Patients with Reflux Esophagitis.  Am. J. Gastroenterol. 89(8):1177-84, 1994.
 83.      Sarosiek J, Rourk RM, Piascik R, Namiot Z, Hetzel DP, McCallum RW.  The Effect of Esophageal Mechanical and Chemical Stimuli on Salivary Mucin Secretion in Healthy Individuals. Am. J. Med. Sci. 308(1):23-31, 1994.
 84.      Namiot Z, Sarosiek J, Marcinkiewicz M, Edmunds,MC, McCallum RW.  Declined Human Esophageal Mucin Secretion in Patients with Severe Reflux Esophagitis.  Dig. Dis. Sci. 39(12):2523-9,1994.
 85.      Sarosiek J, McCallum RW. What is the Secretory Potential of Submucosal Mucous Glands within the Human Gullet in Health and Disease? Digestion, 56(Suppl 1):15-23, 1995.
 86.      Sarosiek J, McCallum RW. Esophagoprotection by Prostaglandins: How Far are We From Reaching the Verdict?  Am. J. Gastroenterol. 90(5):847-9, 1995.
 87.      Marcinkiewicz M, Sarosiek J, Edmunds M, Scheurich J, Weiss P, McCallum RW. Monophasic Luminal Release of Prostaglandin E2 in Patients with Reflux Esophagitis Under the Impact of Acid and Acid/Pepsin Solutions: Its Potential Pathogenetic Significance.  J. Clin. Gastroenterol. 21(4):268-74,1995.
 88.      Sarosiek J, McCallum RW. What Role Do Salivary Inorganic Components Play in Health and Disease of the Esophageal Mucosa? Digestion, 56(Suppl 1):24-31, 1995.
 89.      DeRosa J, Marcinkiewicz M, Sarosiek J, Edmunds MC, McCallum RW.  Modulatory Impact of Acid and Pepsin on Esophageal Hydrophobicity in Humans. Am. J. Gastroenterol. 90(11):2020-4, 1995. 
 90.      Sarosiek J, McCallum RW. Do Salivary Organic Components Play a Protective Role in Health and Disease of the Esophageal Mucosa? Digestion, 56(Suppl 1):32-7, 1995.
 91.      Sarosiek J, Scheurich J, Marcinkiewicz M, McCallum RW. Enhancement of Salivary Esophagoprotection: Rationale for a Physiological Approach to Gastroesophageal Reflux Disease. Gastroenterology, 110(3):675-81, 1996.
 92.      Marcinkiewicz M, Peura DA, Sarosiek J.  The Relationship Between the Content of Aggresive and Protective Components in Gastric Juice and Endoscopic Findings After Naproxen Sodium and Acetaminophen Administration. Am. J. Gastroenterol. 91(2):360-5, 1996.
93. Sarosiek J, Marcinkiewicz M, Parolisi S, Peura DA.  Prostaglandin E2 Content in Residual Gastric Juice Reflects Endoscopic Damage to the Gastric Mucosa After Naproxen Sodium Administration.  Am. J. Gastroenterol. 91(5):873-8, 1996.
94. Marcinkiewicz M, Namiot Z, Edmunds MC, McCallum RW, Sarosiek J.  Detrimental Impact of Acid and Pepsin on the Rate of Luminal Release of Transforming Growth Factor a:  Its Potential Pathogenetic Role in the Development of Reflux Esophagitis.  J. Clin. Gastroenterol. 23(4): 261-8, 1996.
95. Marcinkiewicz M, Van Der Linden B, Peura DA, Goldin G, Parolisi S, Sarosiek J.  Impact of Helicobacter pylori Colonization on Immunoreactive Epidermal Growth Factor and Transforming Growth Factor-a in Gastric Juice: Its Potential Pathogenetic Implications.  Dig. Dis. Sci. 41(11): 2150-5, 1996.
96. Namiot Z, Yu ZJ, Piascik R, Hetzel DP, McCallum RW, Sarosiek J. Modulatory Effect of Esophageal Intraluminal Mechanical and Chemical Stressors on Salivary Prostaglandin E2 in Humans.  Am. J. Med. Sci. 313(2):90-8, 1997.
97. Goldin GF, Marcinkiewicz M, Zbroch T, Bityutskiy LP, McCallum RW, Sarosiek J.  Esophagoprotective Potential of Cisapride: An Additional Benefit for Gastroesophageal Reflux Disease.  Dig. Dis. Sci. 42(7):1362-9, 1997.
98. Thielman NM, Marcinkiewicz M, Sarosiek J, Fang GD, Guerrant RL. Role of Platelet-activating Factor in Chinese Hamster Ovary Cell Responses to Cholera Toxin.  J. Clin. Investig. 99(8):1999-2004, 1997.
99. Marcinkiewicz M, Han K, Zbroch T, Poplawski C, Gramley W, Goldin GF, Sarosiek J. The Potential Role of the Esophageal Pre-Epithelial Barrier Components in the Maintenance of Integrity of the Esophageal Mucosa in Patients with Endoscopically Negative Gastroesophageal Reflux Disease. Am. J. Gastroenterol. 95(7):1652-60, 2000.
100. Sarosiek J, Jensen RT, Maton PN, Peura DA, Harlow D, Feng T, McCallum RW, Pisegna J. Salivary and Gastric Epidermal Growth Factor in Patients with Zollinger-Ellison Syndrome: Its Protective Potential. Am. J. Gastroenterol. 95(5):1158-65, 2000.
101. Sarosiek J, McCallum RW. Mechanisms of Oesophageal Mucosal Defence. Bailliere’s Best Pract. Res. Clin. Gastroenterol. 14(5):701-17, 2000.
102. Skoczylas T, Sarosiek I, Sostarich S, McElhinney C, Durham S, Sarosiek J. Significant Enhancement of Gastric Mucin Content after Rabeprazole Administration: Its Potential Clinical Significance in Acid-Related Disorders. Dig. Dis. Sci. 48(2):322-8, 2003.
103. Gindzienski A, Zwierz K, Sarosiek J. The Role of Mucus and Its Components in Protection and Repair within the Alimentary Tract Mucosa: Polish Experience. J. Physiol. Pharmacol. 54(Suppl 3):127-44, 2003.
104. Namiot Z, Sarosiek J, McCallum RW. Secretory Function of the Esophageal Mucosa in Opossum: the Role of Cholinergic, Peptidergic and Histaminergic Pathways.  Rocz. Akad. Med. Bialymst. 49:80-4, 2004.
105. Poplawski C, Gabryelewicz A, McCallum RW, Sarosiek J. Influence of Bile Acids as a Part of Duodenogastroesophageal Reflux on the Secretory Profile of the Esophageal Pre-epithelial Barrier in Healthy Volunteers and Patients with Gastroesophageal Reflux Disease: Its Potential Pathogenetic Implication.  Med. Sci. Rev. 3:101-5, 2004.
106. Poplawski C, Gabryelewicz A, Sarosiek J, McCallum RW.  The Potential Role of Esophageal Protective Factors in the Maintenance of Integrity of the Esophageal Mucosa in Patients with Gastroesophageal Reflux Disease.  Pol. Gastroenterol. 11(5):429-33, 2004.
107. Poplawski C, Gabryelewicz A, McCallum RW, Sarosiek J. Role of Bile Acids and Prostaglandins in Chronic Esophagitis in not Surgical Mouse Model. Adv. Clin. Exp. Med. 14(4):657-61, 2005.
108. Poplawski C, Gabryelewicz A, Sarosiek J, Loftis M, McCallum RW. Bile Acids Accompanied by Acid and Pepsin Stimulate Salivary Secretion, Mediated by the Esophagosalivary Reflex, Both in Controls and Patients with Gastroesophageal Reflux Disease. Adv. Clin. Exp. Med. 14(2):237-45, 2005.
109. Jaworski T, Sarosiek I, Sostarich S, Roeser K, Connor M, Brotze S, Wallner G, Sarosiek J. Restorative Impact of Rabeprazole on Gastric Mucus and Mucin Production Impairment During Naproxen Administration: Its Potential Clinical Significance. Dig. Dis. Sci. 50(2): 357-65, 2005.
110. Poplawski C, Sosnowski D, Szaflarska-Poplawska A, Sarosiek J, McCallum R, Bartuzi Z. Role of Bile Acids, Prostaglandins and COX Inhibitors of Chronic Esophagitis in a Mouse Model. World J. Gastroenterol. 12(11):1739-42, 2006.
111. Majewski M, Jaworski T, Sarosiek I, Sostarich S, Roeser K, Edlavitch S, McCallum R, Wallner G, Kralstein J, Sarosiek J. Significant Enhancement of Esophageal Pre-epithelial Defense by Tegaserod: Implications for an Esophagoprotective Effect. Clin. Gastroenterol. Hepatol. 5(4):430-8, 2007. 
112. Sarosiek I, Olyaee M, Majewski M, Sidorenko E, Roeser K, Sostarich S, Wallner G, Sarosiek J. Significant Increase of Esophageal Mucin Secretion in Patients with Reflux Esophagitis after Healing with Rabeprazole: Its Esophagoprotective Potential. Dig. Dis. Sci. 54:2137-43, 2009. Epub 2008 Dec 3.
113. Sarosiek I, Selover K, Katz L, Semler J, Wildings G, Lackner J, Sitrin M, Kuo B, Chey W, Hasler W, Koch K, Parkman H, Sarosiek J, McCallum R. The Assessment of Regional Gut Transit Times in Healthy Controls and Patients with Gastroparesis Using Wireless Motility Technology. Alim. Pharmacol. Ther. 31:313-22, 2010. 
114. Dias A, Garcia C, Majewski M, Wallner G, McCallum RW, Poplawski C, Sarosiek J. Gastric Juice Prostaglandins and Peptide Growth Factors as Potential Markers of Chronic Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer: Their Potential Clinical Implications Based on this Pilot Study. Dig. Dis. Sci. 56:3220-5, 2011.
115. Triadafilopoulos G, Taddei A, Bechi P, Freschi G, Ringressi M, Degli’Innocenti D, Castiglioni F, Masini E, Majewski M, Wallner G, Sarosiek J, Dillon J, McCallum, R, et.al. Barrett’s Esophagus: Proton Pump Inhibitors and Chemoprevention I. Ann. N.Y. Acad. Sci. 1232:93-113, 2011.
116. Sarosiek J, McCallum, R. Are Esophageal Mucosal Defense Mechanisms Different in BE? Ann. N.Y. Acad. Sci. 1232:96-7, 2011.
117. Majewski M, Wallner G, and Sarosiek J: What Is the Effect of Lubiprostone on Chloride Channel-2 (ClC-2) Driven Secretion of Protective Components of Mucus in the Human Esophagus? Ann. N.Y. Acad. Sci. 1232:99-100, 2011.
118. Chiodini R, Chamberlin W, Sarosiek J, McCallum RW. Crohn’s Disease and the Mycobacterioses: A Quarter Century Later. Causation or Simple Association? Crit. Rev. Microbiol. 38(1):52-93, 2012.
119. Ali MS, Tiscareno-Grejada I, Locovei S, Smiley R, Collins T, Sarosiek J, McCallum R. Gender and Estradiol as Major Factors in the Expression and Dimerization of nNOSα in Rats with Experimental Diabetic Gastroparesis. Dig. Dis. Sci. 57(11):2814-25, 2012. 
120. Sarosiek I, Foster J, Lin Z, Cherry S, Sarosiek J, McCallum R. The Addition of Pyloroplasty as a New Surgical Approach to Enhance Effectiveness of Gastric Electrical Stimulation Therapy in Patients with Gastroparesis. Neurogastroenterol. Motil. 25:134-9, 2013.
121. Chiodini RJ, Dowd SE, Davis B, Galandiuk S, Chamberlin WM, Kuenstner JT, McCallum RW, Zhang J, Sarosiek J. Crohn's disease may be differentiated into 2 distinct biotypes based on the detection of bacterial genomic sequences and virulence genes within submucosal tissues. J. Clin. Microbiol. 47(7):612-20, 2013.  
122. Garcia CJ, Castro-Combs J, Dias A, Alfaro R, Vasallo J, Majewski M, Jaworski T, Wallner G, Sarosiek J. Impairment of Salivary Mucin Production Resulting in Declined Salivary Viscosity during Naproxen Administration as a Potential Link to Upper Alimentary Tract Mucosal Injury. Clin. Transl. Gastroenterol. 4:e40-6. Epub 2013 Jul 25.
123. Rude J, Azimova K, Dominguez C, Sarosiek J, Edlavitch S, Mukherjee D. Depression as a Predictor of Length of Stay in Patients Admitted to the Cardiovascular Intensive Care Unit at a University Medical Center. Angiology, 65(7):580-4, 2014.
124. Skoczylas T, Yandrapu H, Poplawski C, Asadi M, Wallner G, Sarosiek J. Salivary Bicarbonate as a Major Factor in the Prevention of Upper Esophageal Mucosal Injury in Gastroesophageal Reflux Disease. Dig. Dis. Sci. 59 (10):2411-6, 2014.
125. Majewski M, Wallner G, Sarosiek J. Can Stimulation of Salivary and Esophageal Protective Factors Help to Prevent Reflux Esophagitis, BE and Adenocarcinoma Sequelae in GERD? Ann. N. Y. Acad. Sci. 1325:228-9, 2014.
126. Castro-Combs J,  Garcia CJ, Majewski M, Wallner G, Sarosiek J. Impaired Viscosity of Gastric Secretion and Its Mucin Content as Potential Contributing Factors to the Development of Chronic Constipation.  Dig. Dis. Sci. 59(11):2730-4, 2014.
127. Yandrapu H, Marcinkiewicz M, Poplawski C, Namiot Z, Zbroch T, Sarosiek J. A Distinct Salivary Secretory Response Mediated by the Esophago-Salivary Reflex in Patients with Barrett's Esophagus: Its Potential Pathogenetic Implications. Adv. Med. Sci. 59(2):281-7, 2014.
128. Akiyama J, Bertele A, Brock C, Hvid-Jensen F, Ichiya T, Krarup AL, Majewski M, Rubio CA, Sarosiek J, Scarpignato C, Schmidt PT, Teich S, Triadafilopoulos G, Wallner G. Benign and precursor lesions in the esophagus. Ann. N. Y. Acad. Sci. 1325:226-41, 2014.
129. Majewski M, Sarosiek I, Wallner G, Edlavitch S, Sarosiek J. Stimulation of Mucin, Mucus and Viscosity during Lubiprostone in Patients with Chronic Constipation may Potentially Lead to Increase of Lubrication. Clin. Transl. Gastroenterol. 5(12):e66-73. Epub 2014 Dec 18.
130. Azimova K, Rude J, Mallawaarachchi I, Dwivedi A, Sarosiek J, Mukherjee D. Glucose Levels    and Depression in Hispanic Patients Admitted to the Cardiovascular Intensive Care Unit: A Cross-Sectional Study. Angiology, 66(1):57-64, 2015.
131. Yandrapu H, Marcinkiewicz M, Poplawski C, Han K, Zbroch T, Goldin G, Sarosiek I, Namiot Z, Sarosiek J. Role of Saliva in Esophageal Defense: Implications in Patients with Non-erosive Reflux Disease. Am. J. Med. Sci. 349(5):385-91, 2015.
132. Yandrapu H, Sarosiek J. Protective Factors of the Gastric and Duodenal Mucosa: An Overview.  Curr. Gastroenterol. Rep. 17(6):24(1-8), 2015.  
133. Yandrapu H, Marcinkiewicz M, Zbroch T, Poplawski C, Sarosiek I, Namiot Z, Sarosiek J. Impairment of Salivary Protection in Esophageal Defense: Its Implications in Reflux Esophagitis. J. Clin. Gastroenterol. Treat. 1(1):006-12, 2015.
134. Sarosiek I, Bashashati M, Alvarez A, Hall M, Shankar N, Gomez Y, McCallum RW, Sarosiek J. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestine Bacterial Overgrowth in Patients With Chronic Constipation. Am. J. Med. Sci. 352(3):231-238, 2016. Epub 2016 June 21.
135. Sarosiek J.  Does the healing of the esophageal mucosa improve function of esophageal submucosal and salivary glands?  Ann. N. Y. Acad. Sci. 1380(1):155-161, 2016. Epub 2016 Aug 17.
136. Majewski M, Cooper C, Sarosiek I, Wallner G, Roeser K, Edlavitch S, McCallum RW, Sarosiek J. Gastric pH and Therapeutic Responses to Esomeprazole in Patients with Functional Dyspepsia: Potential Clinical Implications. Am. J. Med. Sci. 352(6):582-592, 2016.

 PUBLICATIONS IN BOOKS:
 
  1. Sarosiek J, Marshall BJ, Peura DA, Guerrant RL, McCallum RW. The isolation and maintenance of human gastric epithelial cells in primary culture. In: Griffiths JB, Doyle A, Newell DG (eds), Cell and Tissue Culture: Laboratory Procedures. J. Willey & Sons Ltd. Chichester, England, 1994:10.1-10.8.
  2. Sarosiek J, Namiot Z, Marshall BJ, Peura DA, Guerrant RL, Harlow D, McCallum RW. Break-Down of the Mucus Layer by Helicobacter pylori. In: Helicobacter pylori: Basic Mechanisms to Clinical Cure, R. Hunt & G. Tytgat (eds), Kluwer Academic Publishers, Lancaster, UK, 1994:123-128. 
  3. Sarosiek J, Namiot Z, Piascik R, Hetzel DP, Rourk RM, Edmunds MC, Daniel TM, McCallum R.W. What Part do the Mucous Cells of Submucosal Mucous Glands Play in the Esophageal Pre-Epithelial Barrier. In: The Esophageal Mucosa.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), Elsevier Scientific Publishing Co., New York, NY, 1994:271-290.
  4. McCallum RW, Sarosiek J. May Bacterial Treatment Directed Against Helicobacter pylori have an effect on relapse in the small group of antritis due to Helicobacter pylori combined with reflux? In: The Esophageal Mucosa.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), Elsevier Scientific Publishing Co., New York, NY, 1994:498-480.
  5. Sarosiek J, McCallum RW.  Is There an Explanation for the Predominance of Barrett’s Esophagus and Adenocarcinoma in White Male Patients? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998: 938-43.
  6. Sarosiek J, McCallum RW.  What is the Most Frequent Site of the Stenosis? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:960-963.
  7. Sarosiek J, McCallum RW.  Why is reflux Esophagitis a Predominantly Male Disease? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:497-9.
  8. Marcinkiewicz M, Sarosiek J, McCallum RW.  Could Lowering of Salivary and Esophageal Epidermal Growth Factor in Severe Reflux Esophagitis be Related to the Development of Barrett’s Mucosa? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998: 966-8.
  9. Sarosiek J, Marcinkiewicz M, Zbroch T, McCallum RW.  What Is the Role of Salivary and Esophageal Prostaglandin E2 in Esophageal Protection?. In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:570-4.
  10. Marcinkiewicz M, Zbroch T, Namiot Z, Sarosiek J.  What Is the Relation Between Acid Reflux, Esophageal Glycoconjugate (Mucin) Secretion, and Viscosity? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:540-2.
  11. Zbroch T, Marcinkiewicz M, Namiot Z, Sarosiek J.  Is salivary Prostaglandin E2 Output Stimulated by Esophageal Inflammation?  In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:574-7.
  12. Brown RL, Sarosiek J, McCallum RW. Is Pepsin Concentration related to the Amount or Duration of Acid Exposure? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:352-6.
  13. Brown RL, Sarosiek J, McCallum RW.  Is There a Role for Selective Vagotomy in Addition to Antireflux Surgery? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:355-7.
  14. Brown RL, Sarosiek J, McCallum RW. What Is the Effect of Cholecystokinin A Antagonists (Loxiglumide) on Solid and Liquid Gastric Emptying? In: The Esophagogastric Junction.  R. Giuli, G.N.J. Tytgat, T.R. DeMeester (eds), John Libbey Eurotext Ltd., Paris, 1998:434-6.
  15. Sarosiek J, McCallum RW. Challenge to the Esophageal Pre-epithelial Mucosal Defense in Barrett’s Esophagus and Its Clinical Sequelae.  In: Barrett’s Esophagus and Esophageal Adenocarcinoma, P. Sharma & R. E. Sampliner, (eds), Blackwell Sci., Malden, MA, 2001, 45-58. 
  16. Sarosiek J. Esophageal Mucosal Defense Mechanisms.  In: Reflux Gastro-esophagien de L’adulte (French Edition), Jan Tack & Stan Bruley de Varannes, (eds), Dong Editing, Leuven, Belgium, 2005, 26-39.
  17. Sarosiek J. Majewski M, Jaworski T, Skoczylas T, Wallner G.: Is There a Protective Effect of Acid Suppression Against Esophageal Adenocarcinoma? In: O.E.S.O. The Duodeno-Gastroesophageal Reflux. R. Giuli (ed), John Libbey Eurotext Ltd., Paris, 2006: 304-8.
  18. Sarosiek J. Majewski M, Jaworski T, Skoczylas T, Wallner G.:  What is the role of saliva in NERD? In: O.E.S.O. Gastroesophageal Reflux Disease: From Reflux to Inflammation to Adenocarcinioma. R. Giuli (ed), John Libbey Eurotext Ltd., Paris, 2008.